Form S-11
We note your introduction of the non-GAAP financial measures NOI and Adjusted EBITDA. Please provide the most directly comparable financial measure calculated in accordance with GAAP for these non-GAAP measures; refer to Item 10(e)(1)(i)(A) of Regulation S-K. Additionally, provide a cross-reference herein to the presentation of such non-GAAP financial measures within your prospectus.
No reply letter found.
We note your presentation of the ratio Net debt to Adjusted EBITDA on page 42. Please update your disclosure to present with equal or greater prominence the ratio as calculated using the most directly comparable GAAP financial measure. Refer to footnote 27 of SEC
No reply letter found.
We note your risk factor disclosure that the board of directors may issue additional shares, amend your charter, and change investment and financing policies without shareholder approval. Please include disclosure about how you intend to notify shareholders of such changes.
No reply letter found.
Please clarify whether you intend to utilize the exemptions described for a controlled company.
No reply letter found.
You disclose that your dilution table has given effect to the completion of the formation transactions and the other adjustments described in the unaudited pro forma consolidated financial statements. Please present separately the dilution impact resulting from these transactions before arriving at the Pro Forma net tangible book value per share after the offering.
No reply letter found.
We note your disclosure on page F-49 that the Company does not have enough cash on hand or other legally binding commitments that can be utilized to repay the outstanding amounts of the original $2,350 million ICE4 CMBS loan upon its May 2024 maturity and the Company considers it probable that it will refinance its obligation prior to maturity.Rest of the question
We further note that the original principal amount $1,320 million ICE5 CMBS loan is also due in November 2024. In light of such commitments, please ensure your disclosures herein clearly highlight your ability as of December 31, 2023 to generate and obtain adequate amounts of cash to meet your requirements and your plans for cash in the shortterm based upon your currently available resources, including whether you are relying on external financing including the proceeds from this offering to meet your needs. Please describe any potential constraints that may impact your ability obtain such financing. We refer you to FRC 501.03(a) and Section IV of SEC Release 33-8350.
No reply letter found.
Please provide a more informative analysis and discussion of changes in operating cash flows, including changes in working capital components, for each period presented. In doing so, please explain the underlying reasons for and implications of material changes between periods to provide investors with an understanding of trends and variability in cash flows.
No reply letter found.
Please disclose the approximate dollar value of the amount of each of Mr. Forste’s and Mr. Marchetti’s respective interests in the distributions you made to BGLH and that BGLH made with respect to its Class B units and its Class C units. Please also disclose the approximate dollar value of the amount of each of Mr. Forste’s and Mr.Rest of the question
Marchetti’s respective interests in the distributions that Lineage OP made with respect to its Class B units, and that Lineage OP made to BG Cold with respect to its Class C units. Please see Item 404(a)(4) of Regulation S-K. Please also explain the effect of the formation transaction on any Advance Distribution (as described in footnote 2(c) of your audited financial statements) on the Class C Special Distribution Right, and the interests of Mr. Forste and Mr. Marchetti in such distributions. If Bay Grove, BG Cold, Mr. Forste or Mr. Marchetti will continue to receive or have an interest in any continuing special distributions after the formation transaction, as suggested in disclosure on page 186, please disclose this and explain how these distributions will be determined. Transactions with Lineage OP, LLC, page 181
No reply letter found.
To help investors better understand the nature and impact of the formation transactions, please explain: • The economic terms of one OP unit, given your disclosure that each Legacy Class A OP Unit and Legacy Class B OP unit will be “economically equivalent to one OP unit.” Please also clarify whether the Legacy Class A and B OP units will have characteristics, such as voting or other rights, that are not equivalentRest of the question
to one OP unit. • The difference between the Legacy Class A OP Units and Legacy Class B OP Units, given that they will both be economically equivalent to OP units. • How you are differentiating “certain” and “other existing” Class A and C unit holders for purposes of reclassifying units into Legacy Class A OP Units or Legacy Class B OP Units. • How each Legacy OP Unit will maintain the economic rights of legacy investors to their respective legacy Class A, Class B or Class C units if all units are being reclassified as either Legacy Class A OP Units or Legacy Class B OP Units. • Please clarify whether any special distributions similar to the Special Distibution Right on the Class C units will continue to be made to any holders of Legacy Class A OP Units or Legacy Class B OP Units, or any other persons, after the formation transactions. In this regard, we note disclosure on page 186 that Bay Grove will hold a continuing right to receive certain special distributions from Class A Legacy OP Units of the operating partnership and from BGLH. Please clarify whether this continuing right is a term of the Class A Legacy OP Unit, or if it is a separate contractual right and if so, please file the relevant agreement as an exhibit to the registration statement.
No reply letter found.
Please clarify whether Bay Grove, Mr. Forste or Mr. Marchetti will receive any accrued but undistributed equity or funds in connection with the equity accrual right in connection with the formation transaction or reclassification of the OPEUs. Please also explain the material terms of the equity accrual right, the profits interest and the OPEUs that you refer to in this section.Rest of the question
Also ensure that you disclose the approximate dollar value of the amount of Mr. Forste’s and Mr. Marchetti’s interests in the transactions with Lineage Holdings, as well as in the transactions with Bay Grove, also described on page 182.
No reply letter found.
Please revise the diagram of your company structure to show the ownership and economic and other rights of the Legacy Class A OP Units, the Legacy Class B OP Units, OPEUs and any special distribution rights.
No reply letter found.
Please describe the material terms of the securities of the Operating Partnership, including the Legacy Class A OP Units, Legacy Class B OP Units and common OP units.
No reply letter found.
Disclosure in your risk factor entitled "Future redemption obligations may materially and adversely affect the market price of shares of our common stock . . ." on page 85 indicates that certain investors are entitled to redeem shares of your common stock. We note disclosure on page 197 that there are generally no redemption rights with respect to your common stock.Rest of the question
Please describe any redemption rights that any investors may have with respect to shares of common stock in your Description of Capital Stock, Certain Relationships and Related Party Transactions and elsewhere as appropriate. File any agreement for redemption rights as an exhibit to the registration statement.
No reply letter found.
Please describe your registration rights agreements with BGLH and Mr. Forse and Mr. Marchetti in this section, including the amount of securities subject to the agreements. Please see Item 201(a)(2) of Regulation S-K. (1) Significant Accounting Policies (b) Basis of Presentation and Principles of Consolidation, page F-11
No reply letter found.
We note your disclosure on page F-11, that as of December 31, 2022 and 2021, the Company did not have any VIEs that met the requirements for consolidation. Please clarify whether the Company has identified any VIEs for which the Company determined it is not the primary beneficiary.Rest of the question
To the extent the Company has identified such VIEs, please tell us how the Company considered the disclosure requirements under paragraphs 4, 5A, and 5B of ASC 810-10-50. (q) revenue recognition, page F-18
No reply letter found.
We note your disclosure on page F-15 that the Company accounts for the lease and nonlease components in its arrangements as a single lease component for both lessee and lessor leases for all classes of assets. Please tell us whether you have any arrangements that include multiple components such that a portion of such arrangements would be accounted for under ASC 842 as a lessor and the non-lease element would haveRest of the question
been accounted for under ASC 606 had the Company not applied the practical expedient in ASC 842-10-15-42A. To the extent such arrangements do exist, please further tell us how you considered the guidance in ASC 842-10-15-42B in determining whether the lease or non-lease components are the predominant components in such arrangements and how you were able to conclude that the lease component is always the predominant item in such arrangements.
No reply letter found.
We note your disclosure that separate performance obligations arise within your warehousing operations for different services rendered. We further note that in your Integrated Solutions segment, you provide several types of services including transportation, food sales, redistribution and E-commerce.Rest of the question
Given the various service offerings, please further clarify whether your typical arrangements result in one performance obligation or multiple performance obligations. To the extent you have arrangements that result in multiple performance obligations, please further describe the basis for which the Company allocates the transaction price among the various performance obligations in such arrangements. Refer to ASC 606-10-50-12 and 606-1050-17. (2) Capital Structure and Noncontrolling Interests, page F-21
No reply letter found.
We note your capital structure includes convertible redeemable noncontrolling interests initially measured and recorded at fair value for Preference Shares issued as part of your acquisition of Kloosterboer Group BV.Rest of the question
Regarding such Preference Shares, please further describe how the Company considered and applied the guidance under ASC 480 and the SEC's temporary equity guidance under ASC 480-10-S99-3A including paragraphs 14 through 16 related to its evaluation of the regular and special redemption rights included in such Preference Shares. (7) Equity Method Investments, page F-43
No reply letter found.
We note your disclosure that you have provided summarized financial information for Emergent Cold LatAm Holdings LLC as it was determined to be an equity method investment which was considered material to the Company. Please clarify whether the Company considered such investment to be material consistent with Rule 4-08(g) of Regulation S-X.Rest of the question
To the extent it is, please enhance your disclosure to provide all of the summarized financial information required by Rule 4-08(g)(2) and defined by Rule 102(bb) of Regulation S-X or tell us why such information is not required. (22) Segment Information, page F-71
No reply letter found.
Your table on page F-73 indicates that sales to customers in Europe comprised approximately 22% of your sales for the year ended December 31, 2022 and 19% for the year ended December 31, 2021. Please supplementally confirm that you did not derive a material amount of revenues from external customers from any individual country within Europe for any of the periods presented; refer to ASC 280-10-50-41(a). Exhibits
No reply letter found.
Please file the Registration Rights agreements and non-compete agreements for Mr. Forste and Mr. Marchetti as exhibits to the registration statement. Please also file the consent of any expert who prepared information for you in connection with the offering, as contemplated by disclosure on page i.
No reply letter found.
We note your response to prior comment 1 and updated disclosure. Aside from such non- GAAP financial measures addressed, please ensure that when presenting non-GAAP financial measures throughout your prospectus, you provide with equal or greater prominence the most directly comparable financial measure calculated and presented in accordance with GAAP.Rest of the question
For instance herein you provide NOI growth on a constant currency basis. Specific to your disclosure on a constant currency basis, ensure your disclosure presents the historical amounts and amounts in constant currency and describes the process for calculating the constant currency amounts and the basis of presentation; refer to Question 104.06 of the Division's Compliance and Disclosure Interpretations on Non-GAAP Financial Measures.
No reply letter found.
We note your response to prior comment 2 and reissue the comment. We note while you have provided a reconciliation of Total debt, net to Net debt, thereby providing a reconciliation for each component of the non-GAAP financial measure used in the calculation, please revise to also provide the ratio as calculated using the most directly comparable GAAP financial measures.
No reply letter found.
We note your response to prior comment 9, as well as your disclosure in the registration statement that legacy investors and Bay Grove will enter into one or more investor rights agreements. Please file these agreements as exhibits to the registration statement.
No reply letter found.
We note your response to prior comment 9. Please tell us supplementally, with a view toward disclosure: • what will cause any Legacy Class A OP Units to be reclassified into OP units such that any portion of the special distribution rights of BG Cold in respect of Legacy Class A OP units will be settled; • how you will determine whether special distribution rights "may also be settled upon the making of any earlierRest of the question
distributions to the holder of such Legacy Class A OP rights;" • how you reconcile the statement on page 188 that each Legacy Class A OP Unit will be "economically equivalent to one OP unit" with the "same value and . . . same share of Lineage OP equity as an OP unit," with the statement that the Legacy Class A OP Units will have the "same economic characteristics of the former Lineage OP Class A units and Lineage OP Class C units," given that the former Class A and C units do not share the same economic characteristics prior to the reclassification to Legacy Class A OP Units; • clarify what you mean by the statement that the Lineage OP Class A units not owned by the company and their "corresponding" Lineage OP Class C units will be "combined" and reclassified into Legacy Class A OP Units. For example, if the Lineage OP Class A units and Class C units are held by different holders, it is unclear who would own the Legacy unit after reclassification. If they are held by the same holders (i.e. an individual holder owns both the A and corresponding C), then it is unclear why the C would have the distribution right you describe. We may have further comments upon review of your response.
No reply letter found.
We note that you have revised disclosure to indicate that each Legacy Class A OP Unit and Legacy Class B OP Unit are economically equivalent to one OP unit and that they have the same voting rights and voting power as an OP units.Rest of the question
Please explain what rights are unique to each of the OP Units, the Legacy Class A and Legacy Class B Units, and tell us supplementally, with a view toward disclosure, the purpose of reclassifying into these Legacy Units instead of OP units in the formation transaction. To the extent that they can be reclassified into OP units, please clarify whether it is the company or the holder who has the right to initiate the reclassification, and any other material terms or conditions required to be met in connection with any such reclassification.
No reply letter found.
We note your response to prior comment 13, as well as the references to contractual repurchases. Please file any such agreement as an exhibit to the registration statement. Financial Statements Notes to Consolidated Financial Statements (1) Significant accounting policies and practices (q) Revenue recognition, page F-18
No reply letter found.
We note your response to prior comment 16 and await the revised disclosure of your accounting policy for lessor arrangements in a future registration statement amendment. (2) Capital Structure and Noncontrolling Interests (g) Convertible Redeemable Noncontrolling Interests—Preference Shares, page F-21
No reply letter found.
We note your response to our prior comment 18. Please further clarify whether the $308.3 million original amount recognized upon acquisition after adjusting for the $77.1 million partial redemption and $18.2 million effect of foreign currency is greater than the maximum redemption value, including accrued dividends payable. Exhibits
No reply letter found.
We note your response to prior comment 21 and reissue in part. Please file the covenants not to compete for Mr. Forste and Mr. Marchetti, or any other non-compete agreements you may have, as exhibits to the registration statement.
No reply letter found.
We note your updated disclosure regarding the value-added impact of your global integrated solutions segment. Please address the usefulness of the added disclosure in addressing your competitive strengths and ability to offer additional customer services to grow this line of business.Rest of the question
Given your discussion of centers offering consolidation and drayage services, and allocation of EBITDA under each scenario to your integrated solutions and "warehouses alone," it is unclear whether you are providing additional context to consolidated EBITDA or if you are presenting EBITDA on a segment basis. Therefore, please tell us how you considered Item 10(e) of Regulation S-K in providing such EBITDA amounts, or clarify your basis in GAAP to include such amounts.
No reply letter found.
Please clarify the nature and purpose of the transactions with BG Lineage Holdings, LLC and with Lineage OP, LLC described on pages 207-210, and pages 215-217 under “Formation Transactions.” Consider using descriptive subheadings to distinguish and organize your discussions of: • the conversion of Lineage OP, LLC from a limited liability company to a limited partnership, • the BLGH-managed liquidity and settlementRest of the question
process for BGLH and for Lineage OP, and • the alternative procedures by which Founders Equity Shares associated with the BGLH Class A units and Legacy Class A units will be settled.
No reply letter found.
In connection with prior comment 5, where you discuss the conversion of Lineage OP, LLC from a limited liability company to a limited partnership, please explain the purpose of reclassifying outstanding units into Legacy units and then to OP units instead of directly to OP units in the formation transaction.
No reply letter found.
We note disclosures that Founders Equity Shares will be settled not later than the third anniversary of the IPO, that legacy investors will elect to receive cash and/or securities during the liquidity and settlement process, and that the discussion of cutbacks refers to a “distribution.” Please clarify whether by “distribution” you are referring to the reclassification of Legacy OP Units into OP Units by BGLH duringRest of the question
the three years following the closing of the offering, as described on page 210. Please also clarify the role of the reclassifications in the BLGH-managed liquidity and settlement process for both BLGH and Lineage OP. For example, clarify whether this process will be completed by way of the reclassifications, or whether there are other distributions or transactions in addition to the reclassifications that will be undertaken to complete the liquidity and settlement process.
No reply letter found.
Where you discuss the settlement of the Founders Equity Share of BGLH Class A units and Lineage Class A OP units, please specify what “securities” legacy investors may elect to receive during the managed liquidity and settlement process, and clarify if true, that BG Cold, as the holder of the Founders Equity Share, will receive cash and/or securities consistent with the legacy investors’ elections.
No reply letter found.
Where you discuss the settlement of the Founders Equity Shares, please clarify the sequence of events, including legacy investor elections, what triggers the settlement (for example, whether it is a reclassification initiated by BLGH or some other distribution or transaction), the cutback and the distribution, and clarify what distinguishes the time of the cutback from the time of the distribution.Rest of the question
Please also disclose what security a holder of BGLH Class A or Legacy Class A OP units would hold as a consequence of electing to settle Founders Equity Shares on cut-back securities at the time of the cutback or at the time of the distribution.
No reply letter found.
Please clarify whether your reference to “formation transactions” and the ownership information that follows includes transactions with legacy investors taking place during the three-year liquidity and settlement period. If not, please address how the proportionate interests of public stockholders disclosed here may be affected by those transactions.
No reply letter found.
We note your disclosure here and elsewhere that you describe the formation transactions that LLH MGMT Profits, LLC and LLH MGMT Profits II, LLC will contribute their interests in Lineage Holdings to the operating partnership in exchange for Legacy Class B OP Units.Rest of the question
Where you discuss the treatment of LMEP Units and BGLH Restricted Units in Connection with this Offering on page 217, you state that all outstanding LMEP Units that are unvested at the completion of the offering will be replaced with "equity-based awards in Lineage, Inc. and/or Lineage OP." Please clarify whether these equity interests are the Legacy Class B OP Units or other securities of the company or the operating partnership, and whether and how their issuance may impact the interests of investors in this offering. Please also tell us what consideration you have given to describing the issuance of the equity-based awards in the description of the formation transactions. Business and Properties, page 163
No reply letter found.
We note you removed the table that previously was to set forth a summary schedule of expirations for any customer contracts featuring minimum storage guarantees, and for leases in effect as of December 31, 2023 and for the year beginning January 1, 2024 and each of the periods to be set forth therein. Please amend to provide a schedule of lease expirations; refer to Item 15(f) of Form S-11.
No reply letter found.
We note that you reviewed market data and took into consideration the structure and components of and amount paid under executive compensation programs of comparable peer group companies. Please clarify whether you engaged in benchmarking to base, justify or provide a framework for compensation decisions.Rest of the question
If so, please revise your disclosure to identify the components used for benchmarking and the level at which you benchmark. Please see Item 402(b)(2)(xiv) of Regulation S-K and Question 118.05 of the staff's Regulation S-K Compliance and Disclosure Interpretations.
No reply letter found.
We note that BGLH may determine whether to limit the amount of Securities Settlements relative to the amount of Cash Settlements, and that BGLH will have a contractual right to require Lineage to conduct offerings of shares of your common stock in order to facilitate Cash Settlements.Rest of the question
Please briefly explain what would cause BGLH to so limit the amount of a Securities Settlement or to require Lineage to conduct an offering of shares to facilitate a Cash Settlement, and describe the impact of these events on Lineage and on investors in this offering. Please also disclose what security a holder of BGLH Class A or Legacy Class A OP units would hold following the decision to cut-back Securities Settlements, at the time of the cutback or any distribution. We note disclosures on pages 237, 239, and 253 that in the event that Securities Settlements with respect to BGLH Units or Legacy OP Units are cut back, BG Cold’s Founders Equity Share for BGLH and Lineage OP will be settled at the time of the cutback rather than at the time of the Securities Settlement. So that investors can better understand this disclosure, please clarify, if true, that the effect of a cutback will be to delay Securities Settlements until the third anniversary of the closing of this offering.
No reply letter found.
We note your disclosure in response to prior comment 7 that the settlement of Founders Equity Shares occurs within BGLH or within the Legacy OP Unit class and does not impact BGLH's ownership of Lineage's shares or the operating partnership's total capitalization.Rest of the question
Please clarify whether the elections to settle in cash or securities that the BGLH Unitholders or Legacy OP Unitholders make, or the decision by BGLH or LHR to make cutbacks to Securities Settlements, may affect the public stockholders of Lineage. Financial Statements Notes to Consolidated Financial Statements (23) Immaterial correction of previously issued consolidated financial statements, page F-77
No reply letter found.
We note your disclosure that the Company identified certain errors in its audited consolidated financial statements for the years ended December 31, 2022 and 2021 related to its property tax accruals, acquired deferred tax liabilities and its income tax provision, and that after evaluating these errors it concluded that they were not material to prior periods, individually or in the aggregate.Rest of the question
Provide us with a detailed materiality analysis to support how you determined that the impacted accounts were not quantitatively or qualitatively material to any of the periods presented.
No reply letter found.
We note your disclosure added in response to prior comment 3 that the compensation committee does not "benchmark" pay, but reviews market data as one input in the determination of executive pay, and that you reviewed total compensation of your executives relative to compensation of comparable positions among the peer companies listed on page 214, but did not set compensation at specific target percentiles within theRest of the question
peer group. Please note the staff's view that in the context of Item 402(b)(2)(xiv) of Regulation S-K, "benchmarking" generally entails using compensation data about other companies as a reference point, either in whole or in part, to base, justify or provide a framework for a compensation decision. Please see paragraph 118.05 of the staff's Regulation SC&DI and Item 402(b)(2)(xiv) and revise accordingly. Please also explain where the compensation the company paid to its executives fell within the range of compensation paid by peer companies.
No reply letter found.
We note your disclosure in this section that certain of the underwriters and/or their respective affiliates are lenders under the Delayed Draw Term Loan and will receive their pro rata portion of the approximately $2.4 billion of the net proceeds from this offering used to repay amounts outstanding under such facilities.Rest of the question
We also note disclosure that certain of the underwriters and/or their respective affiliates are lenders under the Revolving Credit Facility, and that you may use proceeds to reduce the outstanding balance thereunder. Please revise this disclosure to clarify which underwriters and/or their affiliates will receive a portion of the net proceeds. Additionally, please tell us whether you are required to have a qualified independent underwriter in accordance with FINRA Rule 5121. In this regard, we note disclosure in the Underwriting section that more than 5% of the net proceeds of the offering are intended to be used to repay amounts owed to these underwriters and their affiliates.
No reply letter found.
We note your auditor included a review report pertaining to the condensed consolidated interim financial information as of and for the interim period ended March 31, 2024. Please address the following: • Regarding the review performed as of March 31, 2024 and the related interim periods presented, your auditor indicates the reviews were conducted "in accordance with the auditing standards of the Public CompanyRest of the question
Accounting Oversight Board (United States) (PCAOB)." Please tell us why your auditor did not perform their review in accordance with the standards of the PCAOB. Refer to AS 4105.09; and • Regarding the audit performed as of December 31, 2023 and 2022, and the fiscal years ended 2023, 2022 and 2021, address the following and revise as necessary:o Tell us why your auditor refers to their report on condensed consolidated balance sheet as of December 31, 2023 and not on the full set of consolidated financial statements as of and for all periods presented; and o Tell us why your auditor indicated their audit was limited to having been performed in accordance with the " auditing standards of the PCAOB," and not in accordance with the standards of the PCAOB as reflected in their report provided elsewhere in the prospectus.
The Company advises the Staff that the review performed as of March 31, 2024 and the related interim periods presented, as well as the audit of the consolidated balance sheet as of December 31, 2023 and the related consolidated statements of operations and comprehensive income (loss), redeemable noncontrolling interests and equity and cash flows for the year then ended, were conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), not just the auditing standards.Read in the replyRest of the answer
The referenced review report has been removed from the Registration Statement and will not be included in any future filings.
*********
Any comments or questions regarding the foregoing should be directed to the undersigned at 213-891-7339. Thank you in advance for your cooperation in connection with this matter.
Please include footnote disclosure to explain the significance to investors of the combined total number of shares of the company's common stock plus the total number of OP units (233,709,319) that will be outstanding after completion of the formation transactions and the offering.Rest of the question
Use of Proceeds, page 110 Please provide additional information regarding the $91.6 million cash grant to certain employees in connection with the offering. Please identify any directors or executive officers who will receive payments from this grant, and tell us what consideration you have given to including disclosure of these payments as compensation or as a related party 2. transaction. Dilution, page 115 3. You disclose an immediate dilution in pro forma net tangible book value per share to new investors totaling $58.31 given the calculation of $17.69 pro forma net tangible book value per share after the formation transactions, this offering and other pro forma adjustments. However assuming the underwriters exercise their option to purchase additional shares, while you disclose pro forma net tangible book value per share would have been $19.30, your disclosure appears to indicate a significant reduction to the immediate dilution in pro forma net tangible book value to $12.47 per share as reflected on page 116, rather than the difference between the mid-point of the IPO price less such $19.30 per share pro forma net tangible book value assuming overallotment exercise. Please advise, and provide to us your per share calculations.
The Company respectfully advises the Staff that footnote 2 on page 46 of theRead in the reply
Registration Statement explains that OP units, other than Legacy OP Units (until they are reclassified as OP units) and OP units issued upon exchange of OPEUs, are redeemable for cash or, at our election, shares of our common stock on a one-for-one basis, subject to adjustment in certain circumstances, beginning 14 months after the original issuance of such units (other than OP units that were previously classified as Legacy OP Units, which have such redemption rights at any time after their reclassification into OPRest of the answer
units and are not subject to such 14-month waiting period).
Also in this review: company letter, Jul 22, 2024, company letter, Jul 22, 2024